FDA inspection

Cima Labs, Inc.: FDA inspection ending Aug 1, 2003

FDA inspection 288898 · Voluntary Action Indicated (VAI) · Eden Prairie, MN

Key facts

Inspection ID 288898
Firm Cima Labs, Inc.
FEI number 1000520140
Address 10000 Valley View Rd
City Eden Prairie
State MN
ZIP 55344-3510
Fiscal year 2003
Inspection end date Aug 1, 2003
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections